Latest News About - complementary theraphy devices

 
Show/hide duplicate news articles.
Filter by countryfromabout
<<10<12345678910>>>10
 
Show/hide duplicate news articles.
<<10<12345678910>>>10

Tools

Load latest edition

Friday, November 22, 2019

3:21:00 AM CET

Subscribe
RSS | MAP

Language Selection

For any category/filter, users can choose:

  1. the language of the categorized news items (e.g. fr and de to display only those news items in French and German)
  2. the language of the user interface (e.g. it for Italian)

In Top Stories, the user can display the largest clusters of news items for one language only (e.g. en shows all clusters in English)

Country Selection

Users can choose:

  1. country mentioned in the news item (articles about a country)
  2. country in which the news item was published (articles from a country)

Languages Collapse menu...Expand menu...Open help...

Select your languages

ar
az
be
bg
bs
ca
cs
da
de
el
en
eo
es
et
fa
fi
fr
ga
ha
he
hi
hr
hu
hy
id
is
it
ja
ka
km
ko
ku
ky
lb
lo
lt
lv
mk
ml
mn
ms
mt
nl
no
pap
pl
ps
pt
ro
ru
rw
se
si
sk
sl
sq
sr
sv
sw
ta
th
tr
uk
ur
vi
zh
all
Show additional languagesHide additional languages

Interface:

Quotes... Extracted quotes

Joe Gordon said: "Bausch + Lomb is committed to supporting research designed to generate learnings about our products as well as broader insights for the eye health community – such as the unique ARMOR surveillance study," External link

finanzen-ch Monday, October 7, 2019 2:00:00 PM CEST

Fred Colen said: "We continue to build a comprehensive portfolio of clinical evidence in support of Tiara and Reducer," External link

markets-businessinsider Monday, September 30, 2019 3:28:00 PM CEST

Mr Hunt said: "You can only do it by actually taking out cost drivers," External link

watoday Wednesday, August 21, 2019 4:28:00 PM CEST

Rachel David said: "Inflated prices for established medical technologies must come down in line with the rest of the world if the private health sector in Australia is to continue its excellent track record in funding innovation," "One of the most commonly used implants, cardiac stents, are five times the price in Australia as they are in New Zealand" External link

watoday Wednesday, August 21, 2019 4:28:00 PM CEST

Andrew Charlton said: "If top performing private health insurance funds constrained their premium growth directly while still sustaining profitability, $210 million can be saved in premium increases," External link

watoday Wednesday, August 21, 2019 4:28:00 PM CEST

Dominique Monnet said: "Our investment in Evofem reflects our strategic shift with a focus on applying our capital and expertise to support the successful development and commercialization of innovative therapeutics by our partner companies," External link

markets-businessinsider Wednesday, August 7, 2019 10:30:00 PM CEST

Most associated names

Daily number of articles in this category

Trend data not available for this selection.